Beyond chemotherapy: targeted therapies in ovarian cancer von Kaye, Stan B, Yap, Timothy A, Carden, Craig P

Volltext

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval von FONG, Peter C, YAP, Timothy A, A'HERN, Roger, TUTT, Andrew, ASHWORTH, Alan, STONE, John, CARMICHAEL, James, SCHELLENS, Jan H. M, DE BONO, Johann S, KAYE, Stan B, BOSS, David S, CARDEN, Craig P, MERGUI-ROELVINK, Marja, GOURLEY, Charlie, DE GREVE, Jacques, LUBINSKI, Jan, SHANLEY, Susan, MESSIOU, Christina

Volltext

Poly(ADP‐Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic von Yap, Timothy A., Sandhu, Shahneen K., Carden, Craig P., de Bono, Johann S.

Volltext

Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2 von Rizzo, Siân, Hersey, Jenny M, Mellor, Paul, Dai, Wei, Santos-Silva, Alessandra, Liber, Daniel, Luk, Louisa, Titley, Ian, Carden, Craig P, Box, Garry, Hudson, David L, Kaye, Stanley B, Brown, Robert

Volltext

Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer von ATTARD, Gerhardt, SWENNENHUIS, Joost F, OOMMEN, Nikhil Babu, HAWCHE, George, JAMESON, Charles, THOMPSON, Emilda, SIPKEMA, Ronald, CARDEN, Craig P, PARKER, Christopher, DEARNALEY, David, KAYE, Stan B, COOPER, Colin S, OLMOS, David, MOLINA, Arturo, COX, Michael E, TERSTAPPEN, Leon W. M. M, DE BONO, Johann S, REID, Alison H. M, VICKERS, Elaine, A'HERN, Roger, LEVINK, Rianne, COUMANS, Frank, MOREIRA, Joana, RIISNAES, Ruth

Volltext

Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors von Jones, Robin L, Kim, Edward S, Nava-Parada, Pilar, Alam, Salma, Johnson, Faye M, Stephens, Andrew W, Simantov, Ronit, Poondru, Srinivasu, Gedrich, Rich, Lippman, Scott M, Kaye, Stan B, Carden, Craig P

Volltext

The association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer von Carden, Craig P, Stewart, Adam, Thavasu, Parames, Kipps, Emma, Pope, Lorna, Crespo, Mateus, Miranda, Susana, Attard, Gerhardt, Garrett, Michelle D, Clarke, Paul A, Workman, Paul, de Bono, Johann S, Gore, Martin, Kaye, Stan B, Banerji, Udai

Volltext

Targeting CYP17: established and novel approaches in prostate cancer von Yap, Timothy A, Carden, Craig P, Attard, Gerhardt, de Bono, Johann S

Volltext

What is the risk of intracranial bleeding during anti-VEGF therapy? von Carden, Craig P, Larkin, James M G, Rosenthal, Mark A

Volltext

Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development? von Carden, Craig P., Sarker, Debashis, Postel-Vinay, Sophie, Yap, Timothy A., Attard, Gerthardt, Banerji, Udai, Garrett, Michelle D., Thomas, George V., Workman, Paul, Kaye, Stan B., de Bono, Johann S.

Volltext

PARP inhibition: targeting the Achillesʼ heel of DNA repair to treat germline and sporadic ovarian cancers von Carden, Craig P, Yap, Timothy A, Kaye, Stan B

Volltext

Eligibility of patients with brain metastases for phase I trials: time for a rethink? von Carden, Craig P, FRACP, Agarwal, Roshan, MRCP, Saran, Frank, Prof, Judson, Ian R, Prof

Volltext

Predictive biomarkers for targeting insulin-like growth factor-I (IGF-I) receptor von Carden, Craig P, Molife, L Rhoda, de Bono, Johann S

Volltext

Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated with Platinum-Doublet Chemothe... von Brunetto, Andre T., Carden, Craig P., Myerson, James, Faria, Ana Luisa, Ashley, Sue, Popat, Sanjay, O'Brien, Mary E.R.

Volltext

Humors of tumors: potential for interaction between cancer type and treating oncologist's personality? von Carden, Craig P, Judson, Ian R

Volltext

Information about cancer clinical trials: An analysis of Internet resources von Carden, Craig P, Jefford, Michael, Rosenthal, Mark A

Volltext

A NOMOGRAM TO PREDICT THE DEVELOPMENT OF A NOMOGRAM von Carden, Craig P., Rosenthal, Mark A.

Volltext

Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer von NATHAN, Paul, ZWEIFEL, Martin, TAYLOR, N. Jane, STIRLING, J. James, LU, Shiao-Ping, LEACH, Martin O, RUSTIN, Gordon J. S, JUDSON, Ian, PADHANI, Anwar R, KOH, Dow-Mu, NG, Matthew, COLLINS, David J, HARRIS, Adrian, CARDEN, Craig, SMYTHE, Jon, FISHER, Nita

Volltext

Small-Cell Lung Cancer, Getting Smaller But Still Difficult to Treat von Carden, Craig P., O'Brien, Mary E.R.

Volltext

Immediate versus delayed chemotherapy in patients with asymptomatic incurable metastatic cancer von CARDEN, Craig P, ROSENTHAL, Mark A

Volltext